Alimuddin Zumla

Sir Alimuddin Zumla, KBE,[10] FRCP, FRCPath, FRSB (born 15 May 1955) is a British Zambian professor of infectious diseases and international health at University College London Medical School. He specialises in infectious and tropical diseases, clinical immunology, and internal medicine, with a special interest in HIV/AIDS, respiratory infections (including COVID-19 and Tuberculosis), and diseases of poverty.[11][12] He is known for his leadership of infectious/tropical diseases research and capacity development activities.[13] He was awarded a Knighthood in the 2017 Queens Birthday Honours list for services to public health and protection from infectious disease.[14] In 2012, he was awarded Zambia's highest civilian honour, the Order of the Grand Commander of Distinguished services - First Division.[15] In 2020, for the third consecutive year, Zumla was recognised by Clarivate Analytics, Web of Science as one of the world's top 1% most cited researchers.[16][17][18]

Sir Alimuddin Zumla KBE, FRCP, FRCPath, FRSB
Born	15 May 1955 Fort Jameson, Northern Rhodesia
Nationality	British
Alma mater	University of Zambia London School of Hygiene & Tropical Medicine Royal Postgraduate Medical School University of Texas Health Science Center at Houston
Known for	Tuberculosis research Tropical medicine Infectious diseases Mass-gathering medicine Coronavirus disease 2019 research
Spouse(s)	Farzana Bhuta
Awards	2020: Mahathir Science Award [1][2] 2018: The Union Medal[3] 2015: Contribution to World Class Research Award[4] 2014: Donald Mackay Medal[5] 2012: Karolinska Institutet Science Award[6] 2011: WHO Stop TB Partnership, Kochon Foundation Prize and Medal[7] 2000: The Albert Chalmers Medal[8] 1999: Weber-Parkes Trust Medal[9]
Scientific career
Fields	Medicine Tuberculosis Global health
Institutions	University College London UCL Hospitals NHS Foundation Trust
Thesis	Characterisation of human monoclonal antibodies to phenolic glycolipid -1 from patients with leprosy : and production of their anti-idiotypes (1987)
Doctoral advisors	Keith McAdam David Isenburg
Website	https://iris.ucl.ac.uk/iris/browse/profile?upi=AZUML60 http://www.unza-uclms.org/

Early life

Alimuddin "Ali" Zumla was born in Northern Rhodesia (now Chipata, Eastern Province, Zambia).[19] His parents Ismail and Aman Zumla were of Gujarati Indian origin.[20] He resided in the Kamwala district of Lusaka. He did his early education at the Lotus Primary School and Prince Philip Secondary School (now Kamwala Secondary School) in Lusaka, and his medical training at the University of Zambia's School of Medicine.[21] As a teenager, he declined a Rhodes Scholarship in order to pursue medical training in Zambia.[22]

In 1980, Zumla moved to London to pursue an MSc in tropical medicine at the University of London.[19] In 1982, he contracted life-threatening tuberculous meningitis, and was told that he would never walk again, but went on to recover and return to work a year and a half later despite disabling and painful neurological sequelae resulting from his meningitis.[22] He went on to pursue doctoral studies on leprosy human monoclonal antibodies at the London School of Hygiene & Tropical Medicine, where his 1987 dissertation (advised by Keith McAdam) merited him the Alan Woodruff Medal.[19][23][24]

Career

Zumla spent a year at the London School of Hygiene and Tropical Medicine gaining the MSc degree in Clinical Tropical Diseases with a distinction and the Murgratroyd Prize. He subsequently worked at The Royal Northern and Royal Free Hospitals under the mentorship of David Geraint James obtaining his Membership of The Royal College of Physicians of London.

After doing a PhD between 1985 and 1987, Zumla worked as infectious diseases registrar and at the Rush Green Regional Hospital for Infectious Diseases in Romford under Ming Yong and Mervyn Medlock. Whilst working at Rush Green Hospital, he identified and notified the first cases of the 1988 Legionnaires' Diseases outbreak which he traced back to Broadcasting House, BBC, central London.[25]

Zumla subsequently spent four years in a senior registrar/honorary lecturer position at the Hammersmith Hospital, Royal Postgraduate Medical School in London under Sir Robert Lechler, and then two years at the University of Texas Center for Infectious Diseases working with Herbert DuPont.[19][23][26] He then returned to his native Zambia to work on AIDS-related opportunistic infections at the University Teaching Hospital in Lusaka before moving to University College London in 1994.[23]

In 2003, there were media reports about a paper of Zumla's in The Lancet discussing a new test developed by a team he led for monitoring CD4 immune cell counts based on dried blood samples.[27] Such counts are used in monitoring AIDS patients taking antiretroviral drug treatments; Zumla's subsequent work has led to development and evaluation of a range of rapid, cheap and more accessible diagnostic tests for TB and respiratory infections for use on patients in developing countries.[28][29]

Zumla was the guest editor of the Lancet TB Series which addressed key issues around TB treatment and diagnosis. The launch was held at the World Health Organisation (WHO) in Geneva on 18 May 2010.[30] As of 2011, Zumla is the director of the Centre for Infectious Diseases and International Health at University College London Medical School, as well as a consultant in infectious diseases at University College Hospital. His research interests include tuberculosis (particularly drug clinical trials, biomarkers, MDR-TB and TB in London), HIV/AIDS, tropical diseases, respiratory infections (and rapid diagnostics thereof), endocarditis, biomarkers, and transrenal DNA.[31]

Zumla's work focuses on improving global health, especially for disadvantaged populations, with an emphasis on assisting poorer and disadvantaged peoples of the world. He established and directs a multi-country collaboration with several African, Middle Eastern, European and United States institutions on collaborative research and training program on TB and HIV/AIDS.[13][32] Zumla and his collaborators have set up research and training programs in Africa, focusing attention on development of local infrastructure and capacity development.[33] Several of his doctoral students now occupy academic positions in institutions in Africa.[19]

Zumla has established north–south partnerships for TB research. His collaborations span five countries in Europe and 10 in sub-Saharan Africa, where he leads several multi-country research projects. His team's research findings have contributed to the development of WHO's management guidelines on treatment and prevention of TB and TB/HIV, and to improvements in the care of patients worldwide.[34]

In 2014, together with colleagues from Public Health England, World Health Organization, London School of Hygiene and Tropical Medicine, and the Middle East, Zumla co-led The Lancet series on Mass Gatherings Medicine which was launched at the World Health Assembly of Ministers of Health in Geneva. This was a Series of reports about different mass gatherings: the London 2012 Olympic and Paralympic Games; the 2012 European Football Championship finals, hosted jointly by Poland and Ukraine; and the 2012 and 2013 Hajj. These reports set out the planning and surveillance systems used to monitor public health risks, and describe the public health experiences and lessons learnt for the planning of future events.[35]

Zumla played a lead role in defining the etiology, epidemiology, mode of transmission of Middle East respiratory syndrome coronavirus.[36][37]

Zumla is a member of the Court of Governors of the London School of Hygiene and Tropical Medicine and is Vice Chair of the Strategic Advisory Group to the European and Developing Countries Clinical Trials Partnership[38]

On 7 April 2015 at an inaugural meeting in Cape Town, South Africa, Zumla and Markus Maeurer from Karolinska Institutet Sweden led and established a new initiative, the Host-Directed Therapies Network (HDT-NET) consortium of 64 global partners to tackle global infectious diseases threats of multi-drug resistant TB and antimicrobial resistance.[39]

In 2020, Zumla was cited as a leading expert on the COVID-19 pandemic.[12][40]

Awards

Zumla has received the Weber Parkes Trust Medal and Prize from the Royal College of Physicians of London in 1999;[23] the Albert Chalmers Medal from the Royal Society of Tropical Medicine and Hygiene in 2002; the Windrush Award for Academic Achievement in 2003; and the 2005 Professional of the year by the "Muslim News" The Muslim News2005 Awards for Excellence.[41] In 2011 and 2012, Zumla received the UK India International Foundation Science Award (2011); the University of Amsterdam Spinoza Leerstoel award (2011); and the World Health Organisation (WHO) STOP TB Partnership Kochon Prize and Medal (2011) and the Karolinska Institutet, Sweden 2012 Annual Science Prize (2012) and honorary doctorate (2016).[42][34]

In October 2012, Zumla was awarded the highest Zambian civilian award by then Zambian president Michael Sata for his outstanding contributions to infectious diseases research in sub-Saharan Africa, development of Zambia's health sector, and training of numerous health personnel. The award, The Grand Commander of the Order of Distinguished Services First Division, was bestowed on Zumla on the 48th anniversary of Zambia's Independence.[43] In 2016 a research consortium led by Zumla won the European and Developing Countries Clinical Trials Partnership prize presented by Zambian President Edgar Lungu.[44] In 2017 Zumla was appointed as National Institute for Health Research a senior investigator.[45] In 2020, for the third year running, he was recognized by Clarivate Analytics, Web of Science as one of the world's top 1% most cited researchers.[46][47][48]

Quotes

"Everyone should hold hands together and move forward in the fight against killer infectious diseases"

Selected works

Zumla has authored more than 650 publications and edited/published 21 medical textbooks, three of which are globally acknowledged classics: Manson's Tropical Diseases 21st and 22nd editions, Tuberculosis: A Comprehensive Clinical Reference which involves 156 global TB experts writing 104 chapters on all aspects of paediatric and adult TB, and Granulomatous Disorders co-edited with D. G. James.[49]

Books

• Zumla, Alimuddin; Johnson, Margaret A.; Miller, Robert (1997), AIDS and respiratory medicine, Chapman & Hall Medical, ISBN 978-0-412-60140-8
• Zumla, Alimuddin; Schaaf, H. Simon (2009), Tuberculosis: An Issue of Clinics in Chest Medicine, Elsevier – Health Sciences Division, ISBN 978-1-4377-1804-1
• Zumla, Alimuddin, Behrens, Ronald H., Memish, Ziad A., Travel Medicine, An Issue of Infectious Disease Clinics (1st ed.), Philadelphia, PA, ISBN 9781455748983, OCLC 815361562CS1 maint: uses authors parameter (link)
• H. Simon Schaaf and Alimuddin Zumla, Tuberculosis: A Comprehensive Clinical Reference

Edited works

• Cook, Gordon C; Zumla, Alimuddin, eds. (2008), Manson's Tropical Diseases (22nd ed.), London: Elsevier Harcourt Brace Publishing Group, ISBN 978-1-4160-4470-3
• Schaaf, H. Simon; Zumla, Alimuddin, eds. (2009), Tuberculosis: a comprehensive clinical reference, Saunders/Elsevier, ISBN 978-1-4160-3988-4

Journal papers

• Carsetti, Rita; Quintarelli, Concetta; Quinti, Isabella; Piano Mortari, Eva; Zumla, Alimuddin; Ippolito, Giuseppe; Locatelli, Franco (2020). "The immune system of children: the key to understanding SARS-CoV-2 susceptibility?". The Lancet Child & Adolescent Health. 4 (6): 414–416. doi:10.1016/S2352-4642(20)30135-8. PMC 7202830. PMID 32458804.
• Zumla, Alimuddin; Hui, David S; Perlman, Stanley (2015). "Middle East respiratory syndrome". The Lancet. 386 (9997): 995–1007. doi:10.1016/S0140-6736(15)60454-8. PMC 4721578. PMID 26049252.
• McCloskey, B.; Endericks, T.; Catchpole, M.; Zambon, M.; McLauchlin, J.; Shetty, N.; Manuel, R.; Turbitt, D.; Smith, G.; Crook, P.; Severi, E.; Jones, J.; Ibbotson, S.; Marshall, R.; Smallwood, C. A. H.; Isla, N.; Memish, Z. A.; Al-Rabeeah, A. A.; Barbeschi, M.; Heymann, D. L.; Zumla, A. (2014). "London 2012 Olympic and Paralympic Games: Public health surveillance and epidemiology". The Lancet. 383 (9934): 2083–2089. doi:10.1016/S0140-6736(13)62342-9. PMC 7138022. PMID 24857700.
• Zumla A., Raviglione M., Hafner R., Fordham, von Reyn C. (2013). "Tuberculosis". New England Journal of Medicine. 368 (8): 745–755. doi:10.1056/NEJMra1200894. PMID 23425167.CS1 maint: multiple names: authors list (link)
• Nunn, Andrew J.; Mwaba, Peter B.; Chintu, Chifumbe; Crook, Angela M.; Darbyshire, Janet H.; Ahmed, Yusuf; Zumla, Alimuddin I. (April 2011), "Randomised, placebo-controlled trial to evaluate co-trimoxazole to reduce mortality and morbidity in HIV-infected post-natal women in Zambia (TOPAZ)", Tropical Medicine & International Health, 16 (4): 518–526, doi:10.1111/j.1365-3156.2011.02731.x, PMID 21281407, S2CID 31384786
• Griffiths, C.; Sturdy, P.; Brewin, P.; Bothamley, G.; Eldridge, S.; Martineau, A.; MacDonald, M.; Ramsay, J.; Tibrewal, S.; Levi, S.; Zumla, A.; Feder, G. (2007). "Educational outreach to promote screening for tuberculosis in primary care: A cluster randomised controlled trial". The Lancet. 369 (9572): 1528–34. doi:10.1016/S0140-6736(07)60707-7. PMID 17482983. S2CID 9170497.
• Perkins, M. D.; Roscigno, G.; Zumla, A. (2006), "Progress towards improved tuberculosis diagnostics for developing countries", The Lancet, 367 (9514): 942–3, doi:10.1016/S0140-6736(06)68386-4, PMID 16546544, S2CID 11903281
• Zumla, A; Mullan, Z (2006), "Turning the tide against tuberculosis", The Lancet, 367 (9514): 877–8, doi:10.1016/S0140-6736(06)68355-4, PMID 16546520, S2CID 20666586
• Chintu, C.; Bhat, G. J.; Walker, A. S.; Mulenga, V.; Sinyinza, F.; Lishimpi, K.; Farrelly, L.; Kaganson, N.; Zumla, A.; Gillespie, S. H.; Nunn, A. J.; Gibb, D. M. (2004). "Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): A double-blind randomised placebo-controlled trial". The Lancet. 364 (9448): 1865–71. doi:10.1016/S0140-6736(04)17442-4. PMID 15555666. S2CID 503777.
• Mwaba, P.; Cassol, S.; Pilon, R.; Chintu, C.; Janes, M.; Nunn, A.; Zumla, A. (2003), "Use of dried whole blood spots to measure CD4+ lymphocyte counts in HIV-1-infected patients", The Lancet, 362 (9394): 1459–60, doi:10.1016/S0140-6736(03)14693-4, PMID 14602443, S2CID 34623423
• Mwaba, P.; Cassol, S.; Nunn, A.; Pilon, R.; Chintu, C.; Janes, M.; Zumla, A. (2003), "Whole blood versus plasma spots for measurement of HIV-1 viral load in HIV-infected African patients", The Lancet, 362 (9401): 2067–8, doi:10.1016/S0140-6736(03)15103-3, PMID 14697808, S2CID 21275947
• Chintu, C.; Mudenda, V.; Lucas, S.; Nunn, A.; Lishimpi, K.; Maswahu, D.; Kasolo, F.; Mwaba, P.; Bhat, G.; Terunuma, H.; Zumla, A. (2002), "Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study", The Lancet, 360 (9338): 985–90, doi:10.1016/S0140-6736(02)11082-8, PMID 12383668, S2CID 32379604
• Mwinga, A.; Nunn, A.; Ngwira, B.; Chintu, C.; Warndorff, D.; Fine, P.; Darbyshire, J.; Zumla, A. (2002), "Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial", The Lancet, 360 (9339): 1050–5, doi:10.1016/S0140-6736(02)11141-X, PMID 12383985, S2CID 20654344

Bibliographic databases

• Alimuddin Zumla publications indexed by Google Scholar
• Alimuddin Zumla's publications indexed by the Scopus bibliographic database. (subscription required)

References

1. "2020 MAHATHIR SCIENCE AWARD RECIPIENT IS THOUGHT LEADER IN TB, TB/HIV AND EMERGING AND RE-EMERGING EPIDEMIC INFECTIONS". MSA FOUNDATION. Retrieved 18 August 2020.
2. Halid, Oleh Suzalina (16 August 2020). "Prof Alimuddin terima Anugerah Sains Mahathir ke-11". BH Online (in Malay). Retrieved 18 August 2020.
3. "The 2018 Union awards recognise significant achievement from across the globe". The Union. Retrieved 30 October 2018.
4. UCL Hospitals Biomedical Research Centre. , Staff honoured at excellence awards ceremony, 20 March 2015. Retrieved on 20 March 2015.
5. UCL Hospitals Biomedical Research Centre. , BRC researcher awarded for work in tropical health, 17 October 2014. Retrieved on 23 November 2014.
6. UCL Hospitals Biomedical Research Centre. , Karolinska Institutet Annual Prize Lecture Award 2012, 2 November 2012. Retrieved on 23 November 2014.
7. WHO STOP TB partnership. , 2011 Award Winner, 2011. Retrieved on 23 November 2014.
8. RSTMH. "Archived copy". Archived from the original on 18 December 2014. Retrieved 23 November 2014.CS1 maint: archived copy as title (link), List of past medal holders, 2013. Retrieved on 23 November 2014.
9. RSTMH. "Archived copy" (PDF). Archived from the original (PDF) on 13 July 2012. Retrieved 23 November 2014.CS1 maint: archived copy as title (link), The Weber Parkes Trust Medal and Prize, 199 Vol 7 No. 3-page 5. Retrieved on 23 November 2014.
10. "Prof. Alimuddin Zumla has been made Knight Bachelor of The Most Excellent Order (KBE) | Karolinska Institutet". ki.se. Retrieved 6 March 2020.
11. Kuwema, Moses (14 February 2010), "Zambian doctor in contention for prestigious British award", The Post Zambia, archived from the original on 11 September 2012, retrieved 12 April 2011
12. Halpin, Hayley. "Belfast researchers launch clinical trial for Covid-19 patients using umbilical cord cells". TheJournal.ie. Retrieved 24 June 2020.
13. Prof Ali Zumla, University College London Institutional Research Information System, retrieved 27 December 2012
14. "Central Chancery of the Orders of Knighthood".
15. "ZAMBIAN PROFESSOR BAGS INTERNATIONAL AWARD ~". 23 August 2020. Retrieved 12 November 2020.
16. UCL (30 November 2018). "Professor Sir Ali Zumla cited in global list of influential researchers". Division of Infection and Immunity. Retrieved 22 December 2020.
17. UCL (29 November 2019). "Professor Sir Ali Zumla cited in 2019 global list of influential researchers". Division of Infection and Immunity. Retrieved 22 December 2020.
18. UCL (20 November 2020). "UCL academics recognised in annual global list of influential researchers". UCL News. Retrieved 22 December 2020.
19. "Editorial introduction: Section Editor Alimuddin Zumla", Current Opinion in Pulmonary Medicine, 15 (3): vii, May 2009, doi:10.1097/MCP.0b013e32832a1d8a
20. Ghodiwala, Adam; Mank, Yacoob, eds. (2011), Bharuchi Vahora Patel (PDF), United-Kingdom: y, Gujarati Writers' Guild, p. 96, retrieved 27 December 2012
21. Mwaba, Peter (23 March 2006), "Kamwala Boy Zumla Leads Fight Against Tuberculosis on World TB Day Launch", Times of Zambia, retrieved 22 April 2011
22. Kirby, Tony (April 2013). "Alimuddin Zumla: infectious diseases guru and survivor". The Lancet Infectious Diseases. 13 (4): 301. doi:10.1016/S1473-3099(13)70045-8. ISSN 1474-4457. PMID 23531387.
23. "The Weber Parkes Trust Medal and Prize" (PDF), Bulletin of Tropical Medicine and International Health, 7 (3): 5, 1999, ISSN 1356-0832, archived from the original (PDF) on 13 July 2012
24. Zumla, Alimuddin (1987), Characterisation of human monoclonal antibodies to phenolic glycolipid-1 from patients with leprosy and production of their anti-idiotypes, PhD dissertation, London School of Tropical Medicine and Hygiene. See library record here.
25. Zumla, A.; Weyell, R.; Tettmar, R.E. (1988). "Legionnaires' Disease: Early Lessons from 1988 London Outbreak". The Lancet. 331 (8597): 1275. doi:10.1016/S0140-6736(88)92089-2. ISSN 0140-6736. PMID 2897531. S2CID 33343923.
26. "BMJ Group Lifetime Achievement Award: Professor Alimuddin Zumla", BMJ, 339: b5574, December 2009, doi:10.1136/bmj.b5574, S2CID 220109881
27. "Paper test 'could help HIV care'", BBC News, 31 October 2003, retrieved 12 April 2010
28. Pearson, Helen (31 October 2003), "Cheap test monitors HIV drugs: Dried blood spots could track developing world treatment success", Nature News, doi:10.1038/news031027-11
29. "New blood test boost for HIV drive", The Age, 2 November 2003, retrieved 12 April 2011
30. UCL News. , UCL plays key role in Lancet TB series, 19 May 2010. Retrieved on 26 November 2014.
31. Profile: Alimuddin Zumla, University College Hospital, retrieved 16 April 2011
32. 2011 Award Winner: Professor Alimuddin Zumla, Stop TB Partnership, retrieved 27 December 2012
33. Introduction, University of Zambia – University College London Medical School Research and Training Programme, retrieved 27 December 2012
34. UCL Professor wins trio of prizes for TB work, University College London, 2 November 2011, retrieved 27 December 2012
35. The Lancet. , Mass Gatherings Medicine, 21 May 2014. Retrieved on 26 November 2014.
36. UCL News. Researchers shed light on MERS Coronavirus transmission, 19 June 2013. Retrieved on 26 November 2014.
37. Assiri, A.; McGeer, A.; Perl, T. M.; Price, C. S.; Al Rabeeah, A. A.; Cummings, D. A. T.; Alabdullatif, Z. N.; Assad, M.; Almulhim, A.; Makhdoom, H.; Madani, H.; Alhakeem, R.; Al-Tawfiq, J. A.; Cotten, M.; Watson, S. J.; Kellam, P.; Zumla, A. I.; Memish, Z. A. (2013). "Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus". New England Journal of Medicine. 369 (5): 407–416. doi:10.1056/NEJMoa1306742. PMC 4029105. PMID 23782161.
38. "EDCTP Strategic Advisory Committee", Members of the Strategic Advisory Committee, retrieved 28 March 2015
39. Zumla, Alimuddin; Chakaya, Jeremiah; Hoelscher, Michael; Ntoumi, Francine; Rustomjee, Roxana; Vilaplana, Cristina; Yeboah-Manu, Dorothy; Rasolof, Voahangy; Munderi, Paula; Singh, Nalini; Aklillu, Eleni; Padayatchi, Nesri; Macete, Eusebio; Kapata, Nathan; Mulenga, Modest; Kibiki, Gibson; Mfinanga, Sayoki; Nyirenda, Thomas; Maboko, Leonard; Garcia-Basteiro, Alberto; Rakotosamimanana, Niaina; Bates, Matthew; Mwaba, Peter; Reither, Klaus; Gagneux, Sebastien; Edwards, Sarah; Mfinanga, Elirehema; Abdulla, Salim; Cardona, Pere-Joan; Russell, James B.W.; Gant, Vanya; Noursadeghi, Mahdad; Elkington, Paul; Bonnet, Maryline; Menendez, Clara; Dieye, Tandakha N.; Diarra, Bassirou; Maiga, Almoustapha; Aseffa, Abraham; Parida, Shreemanta; Wejse, Christian; Petersen, Eskild; Kaleebu, Pontiano; Oliver, Matt; Craig, Gill; Corrah, Tumena; Tientcheu, Leopold; Antonio, Martin; Rao, Martin; McHugh, Timothy D.; Sheikh, Aziz; Ippolito, Giuseppe; Ramjee, Gita; Kaufmann, Stefan H. E.; Churchyard, Gavin; Steyn, Andrie; Grobusch, Martin; Sanne, Ian; Martinson, Neil; Madansein, Rajhmun; Wilkinson, Robert J.; Mayosi, Bongani; Schito, Marco; Wallis, Robert S.; Maeurer, Markus (2015). "Towards host-directed therapies for tuberculosis" (PDF). Nature Reviews Drug Discovery. 14 (8): 511–512. doi:10.1038/nrd4696. ISSN 1474-1776. PMID 26184493. S2CID 7418745.
40. "Coronavirologists: Where to find the world's top experts right now". Study International. 15 May 2020. Retrieved 24 June 2020.
41. "Muslim News Awards for Excellence 2005 Shortlist", Muslim News, 25 February 2005, archived from the original on 25 August 2012, retrieved 12 April 2011
42. Karolinska Institutet. , New honorary doctors at Karolinska Institutet 2016, 21 April 2016. Retrieved on 22 April 2016.
43. "Sata honours wives of freedom fighters", Times of Zambia, 24 October 2012, retrieved 27 December 2012
44. "University of Zambia-University College London Medical School awarded Outstanding Research Team | UCLH Biomedical Research Centre". www.uclhospitals.brc.nihr.ac.uk. Retrieved 11 November 2016.
45. "NIHR Senior Investigators 2016" (PDF). Archived from the original (PDF) on 29 March 2017.
46. UCL (30 November 2018). "Professor Sir Ali Zumla cited in global list of influential researchers". Division of Infection and Immunity. Retrieved 22 December 2020.
47. UCL (29 November 2019). "Professor Sir Ali Zumla cited in 2019 global list of influential researchers". Division of Infection and Immunity. Retrieved 22 December 2020.
48. UCL (20 November 2020). "UCL academics recognised in annual global list of influential researchers". UCL News. Retrieved 22 December 2020.
49. Search Results for author Zumla A on PubMed.